These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 11269891)
21. Effect of octreotide on insulin requirement, hepatic glucose production, growth hormone, glucagon and c-peptide levels in type 2 diabetic patients with chronic renal failure or normal renal function. Di Mauro M; Papalia G; Le Moli R; Nativo B; Nicoletti F; Lunetta M Diabetes Res Clin Pract; 2001 Jan; 51(1):45-50. PubMed ID: 11137181 [TBL] [Abstract][Full Text] [Related]
22. Insulin secretion and insulin action in Taiwanese with type 2 diabetes. Shen DC; Kuo SW; Shian LR; Fuh MT; Wu DA; Chen YD; Reaven GM Diabetes Res Clin Pract; 1988 Apr; 4(4):289-93. PubMed ID: 2897274 [TBL] [Abstract][Full Text] [Related]
24. Insulin resistance in patients with polycystic ovaries: its relationship to body weight and androgen levels. Pasquali R; Casimirri F; Venturoli S; Paradisi R; Mattioli L; Capelli M; Melchionda N; Labò G Acta Endocrinol (Copenh); 1983 Sep; 104(1):110-6. PubMed ID: 6137924 [TBL] [Abstract][Full Text] [Related]
25. Effect of the new somatostatin analogue SMS 201-995 on exogenously used insulin. Bayraktar M; Usman A; Koray Z Clin Investig; 1994 Sep; 72(9):669-72. PubMed ID: 7849444 [TBL] [Abstract][Full Text] [Related]
26. Effects of glucagon-like peptide 1 (7-36 amide) on glucose kinetics during somatostatin-induced suppression of insulin secretion in healthy men. Shalev A; Ninnis R; Keller U Horm Res; 1998; 49(5):221-5. PubMed ID: 9568806 [TBL] [Abstract][Full Text] [Related]
27. Dose-dependent effect of octreotide on insulin secretion after OGTT in obesity. Bertoli A; Magnaterra R; Borboni P; Marini MA; Barini A; Fusco A; Bollea MR Horm Res; 1998; 49(1):17-21. PubMed ID: 9438780 [TBL] [Abstract][Full Text] [Related]
28. Glucagon, in concert with insulin, supports the postabsorptive plasma glucose concentration in humans. Breckenridge SM; Cooperberg BA; Arbelaez AM; Patterson BW; Cryer PE Diabetes; 2007 Oct; 56(10):2442-8. PubMed ID: 17606872 [TBL] [Abstract][Full Text] [Related]
29. Diurnal variation of insulin sensitivity in NIDDM patients and normal subjects. Shih KC; Ho LT; Kou HF; Liu PC; Hsiao LC; Li SH; Liu YF; Wu MS J Formos Med Assoc; 1992 Mar; 91(3):263-9. PubMed ID: 1354686 [TBL] [Abstract][Full Text] [Related]
30. Relationship between insulin-mediated glucose disposal and regulation of plasma and adipose tissue lipoprotein lipase. Maheux P; Azhar S; Kern PA; Chen YD; Reuven GM Diabetologia; 1997 Jul; 40(7):850-8. PubMed ID: 9243108 [TBL] [Abstract][Full Text] [Related]
31. Suppression of endogenous insulin secretion regulates the rapid rise of insulin-like growth factor binding protein (IGFBP)-1 levels following acute hypoglycaemia. Cotterill AM; Holly JM; Amiel S; Wass JA Clin Endocrinol (Oxf); 1993 Jun; 38(6):633-9. PubMed ID: 7687525 [TBL] [Abstract][Full Text] [Related]
32. Relationship between insulin-mediated glucose disposal by muscle and adipose tissue lipolysis in healthy volunteers. Pei D; Chen YD; Hollenbeck CB; Bhargava R; Reaven GM J Clin Endocrinol Metab; 1995 Nov; 80(11):3368-72. PubMed ID: 7593453 [TBL] [Abstract][Full Text] [Related]
33. Insulin resistance and insulin secretion are determinants of oral glucose tolerance in normal individuals. Reaven GM; Brand RJ; Chen YD; Mathur AK; Goldfine I Diabetes; 1993 Sep; 42(9):1324-32. PubMed ID: 8349044 [TBL] [Abstract][Full Text] [Related]
34. The relationship between glucose disposal in response to physiological hyperinsulinemia and basal glucose and free fatty acid concentrations in healthy volunteers. Abbasi F; McLaughlin T; Lamendola C; Reaven GM J Clin Endocrinol Metab; 2000 Mar; 85(3):1251-4. PubMed ID: 10720071 [TBL] [Abstract][Full Text] [Related]
35. The effect of the somatostatin analogue octreotide on growth hormone secretion in insulin-dependent diabetics without residual insulin secretion. Wurzburger MI; Prelevic GM; Sonksen PH; Balint-Peric LA Horm Metab Res; 1992 Jul; 24(7):329-32. PubMed ID: 1516889 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of insulin resistance in non-obese subjects with impaired glucose tolerance. Ratzmann KP; Witt S; Schulz B Diabete Metab; 1982 Sep; 8(3):223-8. PubMed ID: 6754494 [TBL] [Abstract][Full Text] [Related]
37. Relationship between skeletal muscle insulin resistance, insulin-mediated glucose disposal, and insulin binding. Effects of obesity and body fat topography. Evans DJ; Murray R; Kissebah AH J Clin Invest; 1984 Oct; 74(4):1515-25. PubMed ID: 6148358 [TBL] [Abstract][Full Text] [Related]
38. Effect of difference in glucose infusion rate on quantification of hepatic glucose production. Sheu WH; Hollenbeck CB; Wu MS; Jaspan JB; Chen YD; Reaven GM J Clin Endocrinol Metab; 1990 May; 70(5):1354-60. PubMed ID: 1970829 [TBL] [Abstract][Full Text] [Related]
39. Methods for quantifying insulin resistance in human immunodeficiency virus-positive patients. Chu JW; Abbasi F; Beatty GW; Khalili M; Koch J; Rosen A; Schmidt JM; Stansell JD; Reaven GM Metabolism; 2003 Jul; 52(7):858-61. PubMed ID: 12870161 [TBL] [Abstract][Full Text] [Related]